COVID-19 Impact on Global Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast 2020-2026

August 2020 | 92 pages | ID: CA5AA3791BB1EN
QYResearch

Abstracts

This report focuses on the global Breast Cancer Diagnostic and Drug Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Diagnostic and Drug Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbott
• Roche
• BioMerieux
• Becton Dickinson
• GE Healthcare
• Hologic
• Philips
• PerkinElmer
• Quest Diagnostics

Market segment by Type, the product can be split into

• Mammography
• Biopsy
• Other

Market segment by Application, split into

• Ductal Carcinoma of Breast
• Invasive Ductal Carcinoma
• Lobular Carcinoma
• Triple Negative Breast Cancer

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Breast Cancer Diagnostic and Drug Technologies status, future forecast, growth opportunity, key market and key players.
• To present the Breast Cancer Diagnostic and Drug Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Breast Cancer Diagnostic and Drug Technologies are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Breast Cancer Diagnostic and Drug Technologies Revenue
1.4 Market Analysis by Type
  1.4.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Mammography
  1.4.3 Biopsy
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application: 2020 VS 2026
  1.5.2 Ductal Carcinoma of Breast
  1.5.3 Invasive Ductal Carcinoma
  1.5.4 Lobular Carcinoma
  1.5.5 Triple Negative Breast Cancer
1.6 Coronavirus Disease 2019 (Covid-19): Breast Cancer Diagnostic and Drug Technologies Industry Impact
  1.6.1 How the Covid-19 is Affecting the Breast Cancer Diagnostic and Drug Technologies Industry
    1.6.1.1 Breast Cancer Diagnostic and Drug Technologies Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Breast Cancer Diagnostic and Drug Technologies Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Breast Cancer Diagnostic and Drug Technologies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Breast Cancer Diagnostic and Drug Technologies Market Perspective (2015-2026)
2.2 Breast Cancer Diagnostic and Drug Technologies Growth Trends by Regions
  2.2.1 Breast Cancer Diagnostic and Drug Technologies Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Breast Cancer Diagnostic and Drug Technologies Historic Market Share by Regions (2015-2020)
  2.2.3 Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Breast Cancer Diagnostic and Drug Technologies Market Growth Strategy
  2.3.6 Primary Interviews with Key Breast Cancer Diagnostic and Drug Technologies Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Breast Cancer Diagnostic and Drug Technologies Players by Market Size
  3.1.1 Global Top Breast Cancer Diagnostic and Drug Technologies Players by Revenue (2015-2020)
  3.1.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Players (2015-2020)
  3.1.3 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio
  3.2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Diagnostic and Drug Technologies Revenue in 2019
3.3 Breast Cancer Diagnostic and Drug Technologies Key Players Head office and Area Served
3.4 Key Players Breast Cancer Diagnostic and Drug Technologies Product Solution and Service
3.5 Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Type (2015-2020)
4.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Type (2021-2026)

5 BREAST CANCER DIAGNOSTIC AND DRUG TECHNOLOGIES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020)
5.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size (2015-2020)
6.2 Breast Cancer Diagnostic and Drug Technologies Key Players in North America (2019-2020)
6.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020)
6.4 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size (2015-2020)
7.2 Breast Cancer Diagnostic and Drug Technologies Key Players in Europe (2019-2020)
7.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020)
7.4 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020)

8 CHINA

8.1 China Breast Cancer Diagnostic and Drug Technologies Market Size (2015-2020)
8.2 Breast Cancer Diagnostic and Drug Technologies Key Players in China (2019-2020)
8.3 China Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020)
8.4 China Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Breast Cancer Diagnostic and Drug Technologies Market Size (2015-2020)
9.2 Breast Cancer Diagnostic and Drug Technologies Key Players in Japan (2019-2020)
9.3 Japan Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020)
9.4 Japan Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size (2015-2020)
10.2 Breast Cancer Diagnostic and Drug Technologies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020)
10.4 Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020)

11 INDIA

11.1 India Breast Cancer Diagnostic and Drug Technologies Market Size (2015-2020)
11.2 Breast Cancer Diagnostic and Drug Technologies Key Players in India (2019-2020)
11.3 India Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020)
11.4 India Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size (2015-2020)
12.2 Breast Cancer Diagnostic and Drug Technologies Key Players in Central & South America (2019-2020)
12.3 Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020)
12.4 Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott
  13.1.1 Abbott Company Details
  13.1.2 Abbott Business Overview and Its Total Revenue
  13.1.3 Abbott Breast Cancer Diagnostic and Drug Technologies Introduction
  13.1.4 Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020))
  13.1.5 Abbott Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Breast Cancer Diagnostic and Drug Technologies Introduction
  13.2.4 Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 BioMerieux
  13.3.1 BioMerieux Company Details
  13.3.2 BioMerieux Business Overview and Its Total Revenue
  13.3.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Introduction
  13.3.4 BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
  13.3.5 BioMerieux Recent Development
13.4 Becton Dickinson
  13.4.1 Becton Dickinson Company Details
  13.4.2 Becton Dickinson Business Overview and Its Total Revenue
  13.4.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Introduction
  13.4.4 Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
  13.4.5 Becton Dickinson Recent Development
13.5 GE Healthcare
  13.5.1 GE Healthcare Company Details
  13.5.2 GE Healthcare Business Overview and Its Total Revenue
  13.5.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Introduction
  13.5.4 GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
  13.5.5 GE Healthcare Recent Development
13.6 Hologic
  13.6.1 Hologic Company Details
  13.6.2 Hologic Business Overview and Its Total Revenue
  13.6.3 Hologic Breast Cancer Diagnostic and Drug Technologies Introduction
  13.6.4 Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
  13.6.5 Hologic Recent Development
13.7 Philips
  13.7.1 Philips Company Details
  13.7.2 Philips Business Overview and Its Total Revenue
  13.7.3 Philips Breast Cancer Diagnostic and Drug Technologies Introduction
  13.7.4 Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
  13.7.5 Philips Recent Development
13.8 PerkinElmer
  13.8.1 PerkinElmer Company Details
  13.8.2 PerkinElmer Business Overview and Its Total Revenue
  13.8.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Introduction
  13.8.4 PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
  13.8.5 PerkinElmer Recent Development
13.9 Quest Diagnostics
  13.9.1 Quest Diagnostics Company Details
  13.9.2 Quest Diagnostics Business Overview and Its Total Revenue
  13.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Introduction
  13.9.4 Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
  13.9.5 Quest Diagnostics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Breast Cancer Diagnostic and Drug Technologies Key Market Segments
Table 2. Key Players Covered: Ranking by Breast Cancer Diagnostic and Drug Technologies Revenue
Table 3. Ranking of Global Top Breast Cancer Diagnostic and Drug Technologies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Mammography
Table 6. Key Players of Biopsy
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Breast Cancer Diagnostic and Drug Technologies Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Breast Cancer Diagnostic and Drug Technologies Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Breast Cancer Diagnostic and Drug Technologies Players to Combat Covid-19 Impact
Table 13. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2015-2020)
Table 17. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Breast Cancer Diagnostic and Drug Technologies Market Growth Strategy
Table 23. Main Points Interviewed from Key Breast Cancer Diagnostic and Drug Technologies Players
Table 24. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Players (2015-2020) (Million US$)
Table 25. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Players (2015-2020)
Table 26. Global Top Breast Cancer Diagnostic and Drug Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Diagnostic and Drug Technologies as of 2019)
Table 27. Global Breast Cancer Diagnostic and Drug Technologies by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Breast Cancer Diagnostic and Drug Technologies Product Solution and Service
Table 30. Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020) (Million US$)
Table 33. Global Breast Cancer Diagnostic and Drug Technologies Market Size Share by Type (2015-2020)
Table 34. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2021-2026)
Table 35. Global Breast Cancer Diagnostic and Drug Technologies Market Size Share by Application (2015-2020)
Table 36. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020) (Million US$)
Table 37. Global Breast Cancer Diagnostic and Drug Technologies Market Size Share by Application (2021-2026)
Table 38. North America Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2019-2020)
Table 40. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020) (Million US$)
Table 41. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2015-2020)
Table 42. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020) (Million US$)
Table 43. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2015-2020)
Table 44. Europe Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2019-2020)
Table 46. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2015-2020)
Table 48. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2015-2020)
Table 50. China Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2019-2020) (Million US$)
Table 51. China Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2019-2020)
Table 52. China Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020) (Million US$)
Table 53. China Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2015-2020)
Table 54. China Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020) (Million US$)
Table 55. China Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2015-2020)
Table 56. Japan Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2019-2020)
Table 58. Japan Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2015-2020)
Table 60. Japan Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2019-2020)
Table 64. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2015-2020)
Table 66. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2015-2020)
Table 68. India Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2019-2020) (Million US$)
Table 69. India Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2019-2020)
Table 70. India Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020) (Million US$)
Table 71. India Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2015-2020)
Table 72. India Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020) (Million US$)
Table 73. India Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Breast Cancer Diagnostic and Drug Technologies Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Breast Cancer Diagnostic and Drug Technologies Market Share (2019-2020)
Table 76. Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2015-2020)
Table 78. Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Product
Table 88. Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020) (Million US$)
Table 89. Roche Recent Development
Table 90. BioMerieux Company Details
Table 91. BioMerieux Business Overview
Table 92. BioMerieux Product
Table 93. BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020) (Million US$)
Table 94. BioMerieux Recent Development
Table 95. Becton Dickinson Company Details
Table 96. Becton Dickinson Business Overview
Table 97. Becton Dickinson Product
Table 98. Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020) (Million US$)
Table 99. Becton Dickinson Recent Development
Table 100. GE Healthcare Company Details
Table 101. GE Healthcare Business Overview
Table 102. GE Healthcare Product
Table 103. GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020) (Million US$)
Table 104. GE Healthcare Recent Development
Table 105. Hologic Company Details
Table 106. Hologic Business Overview
Table 107. Hologic Product
Table 108. Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020) (Million US$)
Table 109. Hologic Recent Development
Table 110. Philips Company Details
Table 111. Philips Business Overview
Table 112. Philips Product
Table 113. Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020) (Million US$)
Table 114. Philips Recent Development
Table 115. PerkinElmer Business Overview
Table 116. PerkinElmer Product
Table 117. PerkinElmer Company Details
Table 118. PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020) (Million US$)
Table 119. PerkinElmer Recent Development
Table 120. Quest Diagnostics Company Details
Table 121. Quest Diagnostics Business Overview
Table 122. Quest Diagnostics Product
Table 123. Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020) (Million US$)
Table 124. Quest Diagnostics Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Type: 2020 VS 2026
Figure 2. Mammography Features
Figure 3. Biopsy Features
Figure 4. Other Features
Figure 5. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application: 2020 VS 2026
Figure 6. Ductal Carcinoma of Breast Case Studies
Figure 7. Invasive Ductal Carcinoma Case Studies
Figure 8. Lobular Carcinoma Case Studies
Figure 9. Triple Negative Breast Cancer Case Studies
Figure 10. Breast Cancer Diagnostic and Drug Technologies Report Years Considered
Figure 11. Global Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions: 2020 VS 2026
Figure 13. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Players in 2019
Figure 16. Global Top Breast Cancer Diagnostic and Drug Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Diagnostic and Drug Technologies as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Breast Cancer Diagnostic and Drug Technologies Revenue in 2019
Figure 18. North America Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbott Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
Figure 27. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Roche Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
Figure 29. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BioMerieux Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
Figure 31. Becton Dickinson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Becton Dickinson Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
Figure 33. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GE Healthcare Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
Figure 35. Hologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Hologic Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
Figure 37. Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Philips Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
Figure 39. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. PerkinElmer Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
Figure 41. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Quest Diagnostics Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed